A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
about
The epidermal growth factor receptor (EGFR / HER-1) gatekeeper mutation T790M is present in European patients with early breast cancer.An integrated network platform for contextual prioritization of drugs and pathwaysHER2-mTOR signaling-driven breast cancer cells require ER-associated degradation to survive.Impacts of somatic mutations on gene expression: an association perspective.Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomasMachine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls
P2860
A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
@en
A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
@nl
type
label
A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
@en
A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
@nl
prefLabel
A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
@en
A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
@nl
P2860
P356
P1433
P1476
A comparative survey of functional footprints of EGFR pathway mutations in human cancers
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.452
P407
P577
2013-10-28T00:00:00Z